Characterization of a Shiga-toxin 1-resistant stock of Vero cells

Microbiology and Immunology

Volumn 48, Issue 5, 2004, Pages 377-387

  Sekino, Takaomi ^a,c   Kiyokawa, Nobutaka ^a   Taguchi, Tomoko ^a   Takenouchi, Hisami ^a   Matsui, Jun ^a   Tang, Wei Ran ^a   Suzuki, Toyo ^a   Nakajima, Hideki ^a   Saito, Masahiro ^a   Ohmi, Kazuhiro ^a   Katagiri, Yohko U ^a   Okita, Hajime ^a   Nakao, Hiroshi ^b   Takeda, Tae ^a   Fujimoto, Junichiro ^a  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

^c YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Globotriaocyl ceramide; Shiga toxin; Toxin resistant; Vero cells

Indexed keywords

BUTYRIC ACID; GLOBOTRIAOSYLCERAMIDE; GLYCOSPHINGOLIPID; MONOCLONAL ANTIBODY; VEROTOXIN 1;

ANIMAL CELL; ARTICLE; BINDING ASSAY; CONFOCAL MICROSCOPY; CORRELATION ANALYSIS; CYTOTOXICITY; INTRACELLULAR TRANSPORT; LIPID ANALYSIS; NITROBLUE TETRAZOLIUM TEST; NONHUMAN; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN TRANSPORT; SERUM; VERO CELL;

ANIMALIA; NEGIBACTERIA;

EID: 2442655048     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2004.tb03527.x     Document Type: Article

References (41)

1. DeGrandis, S., Law, H., Brunton, J., Gyles, C., and Lingwood, C.A. 1989. Globotetraosylceramide is recognized by the pig edema disease toxin. J. Biol. Chem. 264: 12520-12525.
2. Fujimoto, J., Ishimoto, K., Kiyokawa, N., Tanaka, S., Ishii, E., and Hata, J. 1988. Immunocytological and immunochemical analysis on the common acute lymphoblastic leukemia antigen (CALLA): evidence that CALLA on ALL cells and granulocytes are structurally related. Hybridoma 7: 227-236.
3. Garred, O., Dubinina, E., Holm, P.K., Olsnes, S., van Deurs, B., Kozlov, J.V., and Sandvig, K. 1995. Role of processing and intracellular transport for optimal toxicity of Shiga toxin and toxin mutants. Exp. Cell Res. 218: 39-49.
4. Hansen, M.B., Nielsen, S.E., and Berg, K. 1989. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods 119: 203-210.
5. Hughes, A.K., Stricklett, P.K., and Kohan, D.E. 1998. Cytotoxic effect of Shiga toxin-1 on human proximal tubule cells. Kidney Int. 54: 426-437.
6. Inward, C.D., Williams, J., Chant, I., Crocker, J., Milford, D.V., Rose, P.E., and Taylor, C.M. 1995. Verocytotoxin-1 induces apoptosis in vero cells. J. Infect. 30: 213-218.
7. Kaplan, B.S., Cleary, T.G., and Obrig, T.G. 1990. Recent advances in understanding the pathogenesis of the hemolytic uremic syndromes. Pediatr. Nephrol. 4: 276-283.
8. Karpman, D., Hakansson, A., Perez, M.T., Isaksson, C., Carlemalm, E., Caprioli, A., and Svanborg, C. 1998. Apoptosis of renal cortical cells in the hemolytic-uremic syndrome: in vivo and in vitro studies. Infect. Immun. 66: 636-644.
9. Katagiri, U.Y., Mori, T., Nakajima, H., Katagiri, C., Taguchi, T., Takeda, T., Kiyokawa, N., and Fujimoto, J. 1999. Activation of Src family kinase Yes induced by Shiga toxin binding to globotriaosyl ceramide (Gb3/CD77) in low density, detergent-insoluble microdomains. J. Biol. Chem. 274: 35278-35282.
10. Kaye, S.A., Louise, C.B., Boyd, B., Lingwood, C.A., and Obrig, T.G. 1993. Shiga toxin-associated hemolytic uremic syndrome: interleukin-1β enhancement of Shiga toxin cytotoxicity toward human vascular endothelial cells in vitro. Infect. Immun. 61: 3886-3891.
11. Kiarash, A., Boyd, B., and Lingwood, C.A. 1994. Glycosphingolipid receptor function is modified by fatty acid content. Verotoxin 1 and verotoxin 2c preferentially recognize different globotriaosyl ceramide fatty acid homologues. J. Biol. Chem. 269: 11138-11146.
12. Kiyokawa, N., Taguchi, T., Mori, T., Uchida, H., Sato, N., Takeda, T., and Fujimoto, J. 1998. Induction of apoptosis in normal human renal tubular epithelial cells by Escherichia coli Shiga toxins 1 and 2. J. Infect. Dis. 178: 178-184.
13. Kongmuang, U., Honda, T., and Miwatani, T. 1988. Isolation of Shiga toxin-resistant Vero cells and their use for easy identification of the toxin. Infect. Immun. 56: 2491-2494.
14. Konowalchuk, J., Speirs, J.I., and Stavric, S. 1977. Vero response to a cytotoxin of Escherichia coli. Infect. Immun. 18: 775-779.
15. Kozlov, Y.V., Kabishev, A.A., Lukyanov, E.V., and Bayev, A.A. 1988. The primary structure of the operons coding for Shigella dysenteriae toxin and temperature phage H30 shiga-like toxin. Gene 67: 213-221.
16. Li, R., Manela, J., Kong, Y., and Ladisch, S. 2000. Cellular gangliosides promote growth factor-induced proliferation of fibroblasts. J. Biol. Chem. 275: 34213-34223.
17. Lingwood, C.A. 1996. Role of verotoxin receptors in pathogenesis. Trends Microbiol. 4: 147-153.
18. Mangeney, M., Lingwood, C.A., Taga, S., Caillou, B., Tursz, T., and Wiels, J. 1993. Apoptosis induced in Burkitt's lymphoma cells via Gb3/CD77, a glycolipid antigen. Cancer Res. 53: 5314-5319.
19. Melton-Celsa, A.R., and O'Brien, A.D. 1998. Escherichia coli O157:H7 and other Shiga toxin-producing E. coli strains, p. 121-128. In Kaper, J.B., and O'Brien, A.D. (eds), Structure, biology, and relative toxicity of Shiga toxin family members for cells and animals, ASM Press, Washington, D.C.
20. Mizuguchi, M., Tanaka, S., Fujii, I., Tanizawa, H., Suzuki, Y., Igarashi, T., Yamanaka, T., Takeda, T., and Miwa, M. 1996. Neuronal and vascular pathology produced by verocytotoxin 2 in the rabbit central nervous system. Acta Neuropathol. (Berl.) 91: 254-262.
21. Nakajima, H., Katagiri, Y.U., Kiyokawa, N., Taguchi, T., Suzuki, T., Sekino, T., Mimori, K., Saito, M., Nakao, H., Takeda, T., and Fujimoto, J. 2001. Single-step method for purification of Shiga toxin-1 B subunit using receptor-mediated affinity chromatography by globotriaosylceramide-conjugated octyl sepharose CL-4B. Protein Expr. Purif. 22: 267-275.
22. Noda, M., Yutsudo, T., Nakabayashi, N., Hirayama, T., and Takeda, Y. 1987. Purification and some properties of Shiga-like toxin from Escherichia coli O157: H7 that is immunologically identical to Shiga toxin. Microb. Pathog. 2: 339-349.
23. Obrig, T.G., Del-Vecchio, P.J., Brown, J.E., Moran, T.P., Rowland, B.M., Judge, T.K., and Rothman, S.W. 1988. Direct cytotoxic action of Shiga toxin on human vascular endothelial cells. Infect. Immun. 56: 2373-2378.
24. Ohmi, K., Kiyokawa, N., Takeda, T., and Fujimoto, J. 1998. Human microvascular endothelial cells are strongly sensitive to Shiga toxins. Biochem. Biophys. Res. Commun. 251: 137-141.
25. Olshefski, R., and Ladisch, S. 1996. Intercellular transfer of shed tumor cell gangliosides. FEBS Lett. 386: 11-14.
26. Pellizzari, A., Pang, H., and Lingwood, C.A. 1992. Binding of verocytotoxin 1 to its receptor is influenced by differences in receptor fatty acid content. Biochemistry 31: 1363-1370.
27. Prinetti, A., Iwabuchi, K., and Hakomori, S. 1999. Glycosphingolipid-enriched signaling domain in mouse neuroblastoma Neuro2a cells. Mechanism of ganglioside-dependent neuritogenesis. J. Biol. Chem. 274: 20916-20924.
28. Pudymaitis, A., Armstrong, G., and Lingwood, C.A. 1991. Verotoxin-resistant cell clones are deficient in the glycolipid globotriosylceramide: differential basis of phenotype. Arch. Biochem. Biophys. 286: 448-452.
29. Richardson, S.E., Karmali, M.A., Becker, L.E., and Smith, C.R. 1988. The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections. Hum. Pathol. 19: 1102-1108.
30. Richardson, S.E., Rotman, T.A., Jay, V., Smith, C.R., Becker, L.E., Petric, M., Olivier, N.F., and Karmali, M.A. 1992. Experimental verocytotoxemia in rabbits. Infect. Immun. 60: 4154-4167.
31. Sandvig, K., Garred, O., Prydz, K., Kozlov, J.V., Hansen, S.H., and van Deurs, B. 1992. Retrograde transport of endocytosed Shiga toxin to the endoplasmic reticulum. Nature 358: 510-512.
32. Sandvig, K., and van Deurs, B. 1996. Endocytosis, intracellular transport, and cytotoxic action of Shiga toxin and ricin. Physiol. Rev. 76: 949-966.
33. Simon, M., Cleary, T.G., Hernandez, J.D., and Abboud, H.E. 1998. Shiga toxin 1 elicits diverse biologic responses in mesangial cells. Kidney Int. 54: 1117-1127.
34. Taguchi, T., Uchida, H., Kiyokawa, N., Mori, T., Sato, N., Horie, H., Takeda, T., and Fujimoto, J. 1998. Verotoxins induce apoptosis in human renal tubular epithelium derived cells. Kidney Int. 53: 1681-1688.
35. Takeda, T., Dohi, S., Igarashi, T., Yamanaka, T., Yoshiya, K., and Kobayashi, N. 1993. Impairment by verotoxin of tubular function contributes to the renal damage seen in haemolytic uraemic syndrome. J. Infect. 27: 339-341.
36. Tesh, V.L., Samuel, J.E., Perera, L.P., Sharefkin, J.B., and O'Brien, A.D. 1991. Evaluation of the role of Shiga and Shiga-like toxins in mediating direct damage to human vascular endothelial cells. J. Infect. Dis. 164: 344-352.
37. Tesh, V.L., Ramegowda, B., and Samuel, J.E. 1994. Purified Shiga-like toxins induce expression of proinflammatory cytokines from murine peritoneal macrophages. Infect. Immun. 62: 5085-5094.
38. Uchida, H., Kiyokawa, N., Taguchi, T., Horie, H., Fujimoto, J., and Takeda, T. 1999. Shiga toxins induce apoptosis in pulmonary epithelium derived cells. J. Infect. Dis. 180: 1902-1911.
39. van Setten, P.A., Monnens, L.A., Verstraten, R.G., van den Heuvel, L.P., and van Hinsbergh, V.W. 1996. Effects of verocytotoxin-1 on nonadherent human monocytes: binding characteristics, protein synthesis, and induction of cytokine release. Blood 88: 174-183.
40. van Setten, P.A., van Hinsbergh, V.W., Van den Heuvel, L.P., van der Velden, T.J., van de Kar, N.C., Krebbers, R.J., Karmali, M.A., and Monnens, L.A. 1997. Verocytotoxin inhibits mitogenesis and protein synthesis in purified human glomerular mesangial cells without affecting cell viability: evidence for two distinct mechanisms. J. Am. Soc. Nephrol. 8: 1877-1888.
41. Yiu, S.C., and Lingwood, C.A. 1992. Polyisobutylmethacrylate modifies glycolipid binding specificity of verotoxin 1 in thin-layer chromatogram overlay procedures. Anal. Biochem. 202: 188-192.